Healthcare -
Biotechnology - NASDAQ - US
$ 0.8465
3.31 %
$ 306 M
Market Cap
-1.14
P/E
LXRX - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative LXRX - Lexicon Pharmaceuticals, Inc.
114 M
LAST VALUE
87.73%
2 YEAR CAGR
12.32%
5 YEAR CAGR
20.87%
10 YEAR CAGR